| Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity S Haskill, AA Beg, SM Tompkins, JS Morris, AD Yurochko, ... Cell 65 (7), 1281-1289, 1991 | 926 | 1991 |
| Protection against lethal influenza virus challenge by RNA interference in vivo SM Tompkins, CY Lo, TM Tumpey, SL Epstein Proceedings of the National Academy of Sciences 101 (23), 8682-8686, 2004 | 553 | 2004 |
| Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1 SM Tompkins, ZS Zhao, CY Lo, JA Misplon, T Liu, Z Ye, RJ Hogan, Z Wu, ... Emerging infectious diseases 13 (3), 426, 2007 | 388 | 2007 |
| De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis SM Tompkins, J Padilla, MC Dal Canto, JPY Ting, L Van Kaer, SD Miller The Journal of Immunology 168 (8), 4173-4183, 2002 | 260 | 2002 |
| Orally efficacious broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses JJ Yoon, M Toots, S Lee, ME Lee, B Ludeke, JM Luczo, K Ganti, RM Cox, ... Antimicrobial agents and chemotherapy 62 (8), 10.1128/aac. 00766-18, 2018 | 220 | 2018 |
| One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles JD Driskell, CA Jones, SM Tompkins, RA Tripp Analyst 136 (15), 3083-3090, 2011 | 177 | 2011 |
| Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2 L Nguyen, KA McCord, DT Bui, KM Bouwman, EN Kitova, M Elaish, ... Nature Chemical Biology 18 (1), 81-90, 2022 | 158 | 2022 |
| Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2 L Liu, P Chopra, X Li, KM Bouwman, SM Tompkins, MA Wolfert, ... ACS Central Science 7 (6), 1009-1018, 2021 | 145 | 2021 |
| Verdinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces Influenza A Virus Replication In Vitro and In Vivo O Perwitasari, S Johnson, X Yan, E Howerth, S Shacham, Y Landesman, ... Journal of virology 88 (17), 10228-10243, 2014 | 111 | 2014 |
| Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication A Bakre, P Mitchell, JK Coleman, LP Jones, G Saavedra, M Teng, ... Journal of general virology 93 (11), 2346-2356, 2012 | 101 | 2012 |
| A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins SM Tompkins, PA Rota, JC Moore, PE Jensen Journal of immunological methods 163 (2), 209-216, 1993 | 98 | 1993 |
| Comparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1) KC Bradley, CA Jones, SM Tompkins, RA Tripp, RJ Russell, MR Gramer, ... Virology 413 (2), 169-182, 2011 | 84 | 2011 |
| Interferon lambda upregulates IDO1 expression in respiratory epithelial cells after influenza virus infection JM Fox, JM Crabtree, LK Sage, SM Tompkins, RA Tripp Journal of interferon & cytokine research 35 (7), 554-562, 2015 | 82 | 2015 |
| Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5–based COVID-19 vaccine D An, K Li, DK Rowe, MCH Diaz, EF Griffin, AC Beavis, SK Johnson, ... Science advances 7 (27), eabi5246, 2021 | 79 | 2021 |
| Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge SM Tompkins, Y Lin, GP Leser, KA Kramer, DL Haas, EW Howerth, J Xu, ... Virology 362 (1), 139-150, 2007 | 77 | 2007 |
| SARS-CoV-2 spike protein binds heparan sulfate in a length-and sequence-dependent manner L Liu, P Chopra, X Li, KM Bouwman, SM Tompkins, MA Wolfert, ... | 73 | 2020 |
| Host gene targets for novel influenza therapies elucidated by high‐throughput RNA interference screens VA Meliopoulos, LE Andersen, KF Birrer, KJ Simpson, JW Lowenthal, ... The FASEB journal 26 (4), 1372, 2012 | 71 | 2012 |
| Avian influenza virus isolates from wild birds replicate and cause disease in a mouse model of infection EA Driskell, CA Jones, DE Stallknecht, EW Howerth, SM Tompkins Virology 399 (2), 280-289, 2010 | 69 | 2010 |
| Inhibition of indoleamine 2, 3-dioxygenase enhances the T-cell response to influenza virus infection JM Fox, LK Sage, L Huang, J Barber, KD Klonowski, AL Mellor, ... Journal of general virology 94 (7), 1451-1461, 2013 | 67 | 2013 |
| Virus-vectored influenza virus vaccines RA Tripp, SM Tompkins Viruses 6 (8), 3055-3079, 2014 | 66 | 2014 |
Robert Jeffrey HoganProfessor, University of Georgia在 uga.edu 的电子邮件经过验证
